I have to disagree with you ER. I don’t often do that…For me… I have always been told that information is power and knowledge to understand what we value. If you don’t see all sides of the subject at hand you will be blindsided and not know what hit you.

As with everyone here in our chat… it is our quest for information and that is good or bad. Does it not help us to make better decisions? Maybe Fartstain has a link to clinical trials.com? Some indisputable facts about Trodelvey we all missed… not likely but what if there was something bad about Trodelvey that made you think what we already believe in… that not only is Leronlimab better but it is way way better?

To dismiss information because of a dislike of the idiot we all see in that Fartstain. Doesn’t seem to smart to me when this is about the competitors drug. He isn’t cutting on Leronlimab…

You and everyone here is smart enough to read between the lines and see the real truth is when we need to. Seeing the article is just more information to process. The title alone of the article tells you there is unseen problems with Trodelvey. Hmmm? Curiosity is a wonderful thing to me.